Aadi Bioscience (AADI)
NASDAQ:AADI

Aadi Bioscience (AADI) Financial Statements

445 Followers

Aadi Bioscience Financial Overview

Aadi Bioscience's market cap is currently ―. The company's EPS TTM is $-2.554; its P/E ratio is -0.61; Aadi Bioscience is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.69. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 5.35M$ 6.33M$ 5.96M$ 6.20M$ 5.87M
Gross Profit$ 4.70M$ 5.40M$ 5.26M$ 5.55M$ 5.34M
EBIT$ -18.23M$ -16.21M$ -16.24M$ -17.91M$ -15.16M
EBITDA$ -18.18M$ -16.17M$ -16.79M$ -18.73M$ -16.33M
Net Income Common Stockholders$ -18.29M$ -16.27M$ -16.30M$ -17.97M$ -15.22M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 88.27M$ 108.84M$ 119.33M$ 134.89M$ 151.17M
Total Assets$ 111.07M$ 132.42M$ 139.66M$ 151.23M$ 170.65M
Total Debt$ 1.16M$ 1.27M$ 1.37M$ 1.47M$ 1.57M
Net Debt$ -87.11M$ -107.58M$ -117.97M$ -133.42M$ -149.61M
Total Liabilities$ 20.61M$ 27.23M$ 21.46M$ 19.81M$ 24.67M
Stockholders Equity$ 90.41M$ 105.19M$ 118.20M$ 131.41M$ 145.99M
Cash Flow-
Free Cash Flow$ -20.39M$ -10.46M$ -13.04M$ -17.48M$ -22.66M
Operating Cash Flow$ -19.65M$ -9.64M$ -11.95M$ -16.79M$ -21.29M
Investing Cash Flow$ 10.55M$ 3.65M$ 12.67M$ 50.56M$ 16.33M
Financing Cash Flow$ -10.00K$ 80.00K$ -75.00K$ 313.00K$ 8.00K
Currency in USD

Aadi Bioscience Earnings and Revenue History

Aadi Bioscience Debt to Assets

Aadi Bioscience Cash Flow

Aadi Bioscience Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis